Drug Database
Back to search

Belgium· BE-AMP-SAM135466-00

Barexal 3 g - 0.125 g

A diosmectit product containing smectite dioctaed, registered in Belgium by Ipsen. The same ATC class is registered in 4 of our 19 countries.

ATC A07BC05

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedBarexal 3 g - 0.125 gATCA07BC05REGISTER NO.BE-AMP-SAM135466-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about smectite dioctaedAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Diosmectit is registered in 4 of 19 countries.

Countries holding a registration under ATC A07BC05 (diosmectit), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose
Search diosmectit products by name

Diosmectit · ATC A07BC05

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Franceprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Smectite Dioctaed
Manufacturer
Ipsen
Country
Belgium (BE)
ATC code
A07BC05
ATC class
Diosmectit
Defined daily dose
9 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    0676874

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under A07BC05

Diosmectit, as other registers publish it.

All diosmectit products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/eb81bcc1-b0f4-4e1f-93a9-854985a6edda
GET /v1/drugs/eb81bcc1-b0f4-4e1f-93a9-854985a6edda?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for oral suspension",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Barexal 3 g - 0.125 g",
  "name_fr": "Barexal 3 g - 0.125 g",
  "name_nl": "Barexal 3 g - 0.125 g",
  "amp_code": "SAM135466-00",
  "strengths": [
    "3000.0000",
    "125.0000",
    "125.0000",
    "3000.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Smectite Dioctaed",
    "Aluminium Hydroxide-Magnesium Carbonate Coprecipitate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diosmectite",
  "authorisation_numbers": [
    "BE135466"
  ]
}
API referenceMCP serverPlans

See everything about diosmectit.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console